This inventor holds 2 USPTO granted patents. Top assignee: Columbia University. Active years: 2012-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012-2016
Title: J S Dileep Kumar: Innovator in Radiolabeled Compounds
Introduction
J S Dileep Kumar is a notable inventor based in Fort Lee, NJ (US). He has made significant contributions to the field of radiolabeled compounds, with a focus on their applications in treating psychiatric disorders. His innovative work has led to the development of two patents that showcase his expertise and dedication to advancing medical science.
Latest Patents
J S Dileep Kumar holds two patents related to radiolabeled compounds. His latest patents include "Radiolabeled compounds and uses thereof," which pertains to radiolabeled compounds labeled with fluorine, bromine, iodine, carbon, or tritium isotopes. These compounds are designed for treating or preventing psychiatric disorders in subjects, stabilizing the mood of individuals with mood disorders, or serving as imaging agents for serotonin receptors. The compositions disclosed in these patents comprise an imaging-effective amount of a radiolabeled compound, highlighting their potential in medical applications.
Career Highlights
J S Dileep Kumar is affiliated with Columbia University, where he continues to engage in research and development in the field of radiolabeled compounds. His work is characterized by a commitment to improving mental health treatment options through innovative scientific approaches.
Collaborations
J S Dileep Kumar collaborates with Joseph John Mann, contributing to the advancement of their shared research interests. Their partnership exemplifies the collaborative spirit that drives innovation in scientific research.
Conclusion
J S Dileep Kumar's contributions to the field of radiolabeled compounds demonstrate his commitment to innovation and improving mental health treatment. His patents reflect a significant advancement in the application of radiolabeled compounds, showcasing the potential for future developments in this important area of research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
